Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 962695, 8 pages
http://dx.doi.org/10.1155/2013/962695
Review Article

Impact of Mannose-Binding Lectin Deficiency on Radiocontrast-Induced Renal Dysfunction

1Department of Infectious Diseases, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
2Laboratory of Clinical Immunology, Department of Biomedicine, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland
3Clinic for Internal Medicine, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland

Received 3 October 2013; Accepted 26 November 2013

Academic Editor: Michele Andreucci

Copyright © 2013 Michael Osthoff and Marten Trendelenburg. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. B. Larson, L. W. Johnson, B. M. Schnell, S. R. Salisbury, and H. P. Forman, “National trends in CT use in the emergency department: 1995–2007,” Radiology, vol. 258, no. 1, pp. 164–173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. E. Tublin, M. E. Murphy, and F. N. Tessler, “Current concepts in contrast media-induced nephropathy,” American Journal of Roentgenology, vol. 171, no. 4, pp. 933–939, 1998. View at Google Scholar · View at Scopus
  3. C. S. Rihal, S. C. Textor, D. E. Grill et al., “Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention,” Circulation, vol. 105, no. 19, pp. 2259–2264, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. W. F. Finn, “The clinical and renal consequences of contrast-induced nephropathy,” Nephrology Dialysis Transplantation, vol. 21, no. 1, pp. i2–i10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. P. A. McCullough, “Contrast-Induced Acute Kidney Injury,” Journal of the American College of Cardiology, vol. 51, no. 15, pp. 1419–1428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. N. H. Lameire, “Contrast-induced nephropathy—prevention and risk reduction,” Nephrology Dialysis Transplantation, vol. 21, no. 1, pp. i11–i23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Klima, A. Christ, I. Marana et al., “Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial,” European Heart Journal, vol. 33, pp. 2071–2079, 2012. View at Google Scholar
  8. M. Kanbay, A. Covic, S. G. Coca, F. Turgut, A. Akcay, and C. R. Parikh, “Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials,” International Urology and Nephrology, vol. 41, no. 3, pp. 617–627, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. P. B. Persson, P. Hansell, and P. Liss, “Pathophysiology of contrast medium-induced nephropathy,” Kidney International, vol. 68, no. 1, pp. 14–22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Tumlin, F. Stacul, A. Adam et al., “Pathophysiology of contrast-induced nephropathy,” American Journal of Cardiology, vol. 98, no. 6, pp. 14–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Seeliger, M. Sendeski, C. S. Rihal, and P. B. Persson, “Contrast-induced kidney injury: mechanisms, risk factors, and prevention,” European Heart Journal, vol. 33, pp. 2007–2015, 2012. View at Google Scholar
  12. M. M. Sendeski, A. B. Persson, Z. Z. Liu et al., “Iodinated contrast media cause endothelial damage leading to vasoconstriction of human and rat vasa recta,” American Journal of Physiology, vol. 303, no. 12, pp. F1592–F1598, 2012. View at Publisher · View at Google Scholar
  13. S. N. Heyman, S. Rosen, M. Khamaisi, J.-M. Idée, and C. Rosenberger, “Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy,” Investigative Radiology, vol. 45, no. 4, pp. 188–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. P. C. Wong, Z. Li, J. Guo, and A. Zhang, “Pathophysiology of contrast-induced nephropathy,” International Journal of Cardiology, vol. 158, pp. 186–192, 2012. View at Google Scholar
  15. J. Seyfarth, P. Garred, and H. O. Madsen, “Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genes,” Molecular Immunology, vol. 43, no. 7, pp. 962–971, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. D. P. Eisen and R. M. Minchinton, “Impact of mannose-binding lectin on susceptibility to infectious diseases,” Clinical Infectious Diseases, vol. 37, no. 11, pp. 1496–1505, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. Ogden, A. DeCathelineau, P. R. Hoffmann et al., “C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells,” Journal of Experimental Medicine, vol. 194, no. 6, pp. 781–795, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. L. R. La Bonte, V. I. Pavlov, Y. S. Tan et al., “Mannose-binding lectin-associated serine protease-1 is a significant contributor to coagulation in a murine model of occlusive thrombosis,” Journal of Immunology, vol. 188, no. 2, pp. 885–891, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. C. Gulla, K. Gupta, A. Krarup et al., “Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot,” Immunology, vol. 129, no. 4, pp. 482–495, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Garred, F. Larsen, J. Seyfarth, R. Fujita, and H. O. Madsen, “Mannose-binding lectin and its genetic variants,” Genes and Immunity, vol. 7, no. 2, pp. 85–94, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. D. P. Eisen, M. M. Dean, M. A. Boermeester et al., “Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection,” Clinical Infectious Diseases, vol. 47, no. 4, pp. 510–516, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Potlukova, J. Jiskra, T. Freiberger et al., “The production of mannan-binding lectin is dependent upon thyroid hormones regardless of the genotype: a cohort study of 95 patients with autoimmune thyroid disorders,” Clinical Immunology, vol. 136, no. 1, pp. 123–129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. C. M. Sørensen, T. K. Hansen, R. Steffensen, J. C. Jensenius, and S. Thiel, “Hormonal regulation of mannan-binding lectin synthesis in hepatocytes,” Clinical and Experimental Immunology, vol. 145, no. 1, pp. 173–182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. R. M. Minchinton, M. M. Dean, T. R. Clark, S. Heatley, and C. G. Mullighan, “Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population,” Scandinavian Journal of Immunology, vol. 56, no. 6, pp. 630–641, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Thiel, P. D. Frederiksen, and J. C. Jensenius, “Clinical manifestations of mannan-binding lectin deficiency,” Molecular Immunology, vol. 43, no. 1-2, pp. 86–96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Auriti, G. Prencipe, R. Inglese et al., “Role of mannose-binding lectin in nosocomial sepsis in critically ill neonates,” Human Immunology, vol. 71, no. 11, pp. 1084–1088, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. F. N. J. Frakking, N. Brouwer, N. K. A. Van Eijkelenburg et al., “Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis,” Clinical and Experimental Immunology, vol. 150, no. 2, pp. 255–262, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Osthoff, A. Rovó, M. Stern et al., “Mannose-binding lectin levels and major infections in a cohort of very long-term survivors after allogeneic stem cell transplantation,” Haematologica, vol. 95, no. 8, pp. 1389–1396, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. C. G. Mullighan, S. Heatley, K. Doherty et al., “Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation,” Blood, vol. 99, no. 10, pp. 3524–3529, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. J. J. W. Verschuren, A. Roos, A. F. M. Schaapherder et al., “Infectious complications after simultaneous pancreas-kidney transplantation: a role for the lectin pathway of complement activation,” Transplantation, vol. 85, no. 1, pp. 75–80, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. W. B. Gorsuch, E. Chrysanthou, W. J. Schwaeble, and G. L. Stahl, “The complement system in ischemia-reperfusion injuries,” Immunobiology, vol. 217, pp. 1026–1033, 2012. View at Google Scholar
  32. M. Osthoff, V. Piezzi, T. Klima et al., “Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction: a post-hoc analysis of a multicenter randomized controlled trial,” BMC Nephrology, vol. 13, p. 99, 2012. View at Google Scholar
  33. L. Wang, Z. Ni, Z. Xie et al., “Analysis of the urine proteome of human contrast-induced kidney injury using two-dimensional fluorescence differential gel electrophoresis/matrix-assisted laser desorption time-of-flight mass spectrometry/liquid chromatography mass spectrometry,” American Journal of Nephrology, vol. 31, no. 1, pp. 45–52, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. C. Walsh, T. Bourcier, K. Takahashi et al., “Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury,” Journal of Immunology, vol. 175, no. 1, pp. 541–546, 2005. View at Google Scholar · View at Scopus
  35. A. Cervera, A. M. Planas, C. Justicia et al., “Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke,” PLoS ONE, vol. 5, no. 2, Article ID e8433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. L. Hart, K. A. Ceonzo, L. A. Shaffer et al., “Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q,” Journal of Immunology, vol. 174, no. 10, pp. 6373–6380, 2005. View at Google Scholar · View at Scopus
  37. M. Zhang, K. Takahashi, E. M. Alicot et al., “Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury,” Journal of Immunology, vol. 177, no. 7, pp. 4727–4734, 2006. View at Google Scholar · View at Scopus
  38. M. Osthoff, M. Katan, F. Fluri et al., “Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients,” PLoS ONE, vol. 6, no. 6, Article ID e21338, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Trendelenburg, P. Theroux, A. Stebbins, C. Granger, P. Armstrong, and M. Pfisterer, “Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention,” European Heart Journal, vol. 31, no. 10, pp. 1181–1187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. B. de Vries, S. J. Walter, C. J. Peutz-Kootstra, T. G. A. M. Wolfs, L. W. E. Van Heurn, and W. A. Buurman, “The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury,” American Journal of Pathology, vol. 165, no. 5, pp. 1677–1688, 2004. View at Google Scholar · View at Scopus
  41. M. Møller-Kristensen, W. Wang, M. Ruseva et al., “Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury,” Scandinavian Journal of Immunology, vol. 61, no. 5, pp. 426–434, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Castellano, R. Melchiorre, A. Loverre et al., “Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage,” American Journal of Pathology, vol. 176, no. 4, pp. 1648–1659, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Van Der Pol, N. Schlagwein, D. J. Van Gijlswijk et al., “Mannan-binding lectin mediates renal ischemia/reperfusion injury independent of complement activation,” American Journal of Transplantation, vol. 12, no. 4, pp. 877–887, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Quintavalle, M. Brenca, F. De Micco et al., “In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis,” Cell Death and Disease, vol. 2, no. 5, article e155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. J. P. Williams, T. T. V. Pechet, M. R. Weiser et al., “Intestinal reperfusion injury is mediated by IgM and complement,” Journal of Applied Physiology, vol. 86, no. 3, pp. 938–942, 1999. View at Google Scholar · View at Scopus
  46. M. R. Weiser, J. P. Williams, F. D. Moore Jr. et al., “Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement,” Journal of Experimental Medicine, vol. 183, no. 5, pp. 2343–2348, 1996. View at Publisher · View at Google Scholar · View at Scopus
  47. W. G. Austen Jr., M. Zhang, R. Chan et al., “Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM,” Surgery, vol. 136, no. 2, pp. 401–406, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Zhang, W. G. Austen Jr., I. Chiu et al., “Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 11, pp. 3886–3891, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. M. N. Busche, V. Pavlov, K. Takahashi, and G. L. Stahl, “Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin,” American Journal of Physiology, vol. 297, no. 5, pp. H1853–H1859, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. M. E. McMullen, M. L. Hart, M. C. Walsh, J. Buras, K. Takahashi, and G. L. Stahl, “Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo,” Immunobiology, vol. 211, no. 10, pp. 759–766, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Renner, D. Strassheim, C. R. Amura et al., “B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion,” Journal of Immunology, vol. 185, no. 7, pp. 4393–4400, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. J. M. Thurman, D. Ljubanovic, C. L. Edelstein, G. S. Gilkeson, and V. M. Holers, “Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice,” Journal of Immunology, vol. 170, no. 3, pp. 1517–1523, 2003. View at Google Scholar · View at Scopus
  53. C. D. Collard, A. Vakeva, M. A. Morrissey et al., “Complement activation after oxidative stress: role of the lectin complement pathway,” American Journal of Pathology, vol. 156, no. 5, pp. 1549–1556, 2000. View at Google Scholar · View at Scopus
  54. C. D. Collard, M. C. Montalto, W. R. Reenstra, J. A. Buras, and G. L. Stahl, “Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1,” American Journal of Pathology, vol. 159, no. 3, pp. 1045–1054, 2001. View at Google Scholar · View at Scopus
  55. A. F. Ducruet, S. A. Sosunov, B. E. Zacharia et al., “The neuroprotective effect of genetic mannose-binding lectin deficiency is not sustained in the subacute phase of stroke,” Translational Stroke Research, vol. 2, no. 4, pp. 588–599, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Megyeri, V. Makó, L. Beinrohr et al., “Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function,” Journal of Immunology, vol. 183, no. 5, pp. 3409–3416, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. S. R. Coughlin, “Thrombin signalling and protease-activated receptors,” Nature, vol. 407, no. 6801, pp. 258–264, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Krarup, R. Wallis, J. S. Presanis, P. Gál, and R. B. Sim, “Simultaneous activation of complement and coagulation by MBL-associated serine protease 2,” PLoS ONE, vol. 2, no. 7, article e623, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Rickli, K. Benou, P. Ammann et al., “Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media,” Clinical Nephrology, vol. 61, no. 2, pp. 98–102, 2004. View at Google Scholar · View at Scopus
  60. M. G. Shlipak, K. Matsushita, J. Arnlov et al., “Cystatin C versus creatinine in determining risk based on kidney function,” The New England Journal of Medicine, vol. 369, pp. 932–943, 2013. View at Google Scholar
  61. W. J. Schwaeble, N. J. Lynch, J. E. Clark et al., “Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 18, pp. 7523–7528, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. A. E. Davis III, S. Cai, and D. Liu, “C1 inhibitor: biologic activities that are independent of protease inhibition,” Immunobiology, vol. 212, no. 4-5, pp. 313–323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. R. Gesuete, C. Storini, A. Fantin et al., “Recombinant C1 inhibitor in brain ischemic injury,” Annals of Neurology, vol. 66, no. 3, pp. 332–342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. F. K. Kerr, A. R. Thomas, L. C. Wijeyewickrema et al., “Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor,” Molecular Immunology, vol. 45, no. 3, pp. 670–677, 2008. View at Publisher · View at Google Scholar · View at Scopus